| 000 | 01687nam a2200421 c 4500 | ||
|---|---|---|---|
| 005 | 20250919214919.0 | ||
| 008 | 171212 2017 flua 001 0 eng | ||
| 020 |
_a9781498746106 _cRM506.00 |
||
| 039 | 9 |
_a201805251635 _bazriq _c201805251634 _dazriq _c201805231056 _dsalmah _y12-12-2017 _zadilla |
|
| 040 |
_dUKM _erda |
||
| 090 |
_aQV37 _b.H236 2017 9HUKM |
||
| 245 | 0 | 0 |
_aHandbook of methods for designing, monitoring and analyzing dose-finding trials / _cedited by John O'Quigley, Alexia Iasonos, Bjorn Bornkamp. |
| 246 | 3 | 0 | _aMethods for designing and monitoring dose finding trials. |
| 264 | 4 |
_aBoca Raton, Florida : _bCRC Press, _c[2017], ©2017. |
|
| 300 |
_axiv, 306 pages : _billustrations ; _c26 cm. |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 490 | 1 | _aChapman & Hall/CRC handbooks of modern statistical methods | |
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 2 | _aDose-Response Relationship, Drug. | |
| 650 | 2 | _aMaximum Tolerated Dose. | |
| 650 | 2 |
_aClinical Trials, Phase I as Topic _xmethods. |
|
| 650 | 2 |
_aClinical Trials, Phase II as Topic _xmethods. |
|
| 650 | 2 | _aDrug Design. | |
| 700 | 1 |
_aO'Quigley, John, _eeditor. |
|
| 700 | 1 |
_aIasonos, Alexia, _eeditor. |
|
| 700 | 1 |
_aBornkamp, Bjorn, _eeditor. |
|
| 830 | 0 | _aChapman & Hall/CRC handbooks of modern statistical methods. | |
| 907 |
_a.b16545126 _b2020-03-30 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQV37 .H236 2017 9HUKM |
||
| 914 | _avtls003629447 | ||
| 949 | _o100983216 | ||
| 990 | _aadilla/azriq | ||
| 991 | _aJabatan Farmasi, PPUKM. | ||
| 998 |
_ah _b2017-12-12 _cm _da _feng _gflu _y0 _z.b16545126 |
||
| 999 |
_c691453 _d691453 |
||